040102512026 - ACD-A SALF Solution for Blood Preservation

This tender, identified by the reference 040102512026, is for the acquisition of an ACD-A (Acid Citrate Dextrose Adenine) solution. This specific solution is utilized for the preservation of blood. ACD-A is a commonly used anticoagulant and preservative additive in blood collection bags, designed to prevent blood clotting and maintain the viability of red blood cells during storage and transfusion. The procurement is essential for blood banks, transfusion centers, hospitals, and other healthcare facilities that handle blood products. Ensuring a reliable supply of high-quality ACD-A solution is critical for safe blood collection, processing, and transfusion practices. The tender aims to secure a sufficient quantity of this vital medical supply to support ongoing blood banking operations and ensure the availability of safe and effective blood components for patients requiring transfusions. The reference indicates this is a procurement for the year 2026.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1,830.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.